TAKHZYRO INJVLST 150MG/ML PEN 2ML
- Active substance
- LANADELUMAB
- Therapeutical formulation
- INJECTIEVLOEISTOF
-
€ 13,945.24 € 13,945.24 excluding delivery costs. Delivery costs are the costs your pharmacist charges for delivering the medicine.
- Own risk
-
€ 13,945.24 € 13,945.24
- Strength
- 150MG/ML
- Supplier
- ORIGINALIS B.V.
- Available outside pharmacies
- No
- Remarks
-
- This medicine is available by prescription only.
- This drug is imported from {0).Ierland.
- EU number
- EU/1/18/1340/010
Variants
- TAKHZYRO INJVLST 150MG/ML WWSP 2ML € 13,444.22 per piece Vergoed
- TAKHZYRO INJVLST 150MG/ML WWSP 2ML € 13,444.22 per piece Vergoed
- TAKHZYRO INJVLST 150MG/ML WWSP 2ML € 13,444.22 per piece Vergoed
- TAKHZYRO INJVLST 150MG/ML WWSP 2ML € 13,444.22 per piece Vergoed
- TAKHZYRO INJVLST 150MG/ML WWSP 2ML € 13,444.23 per piece Vergoed
- TAKHZYRO INJVLST 150MG/ML WWSP 2ML € 13,444.23 per piece Vergoed
- TAKHZYRO INJVLST 150MG/ML FLACON 2ML € 13,945.25 per piece Vergoed
- TAKHZYRO INJVLST 150MG/ML WWSP 1ML € 13,945.25 per piece Deels vergoed